Furosemide and the progression of left ventricular dysfunction in experimental heart failure.
نویسندگان
چکیده
OBJECTIVES We tested the hypothesis that furosemide accelerates the progression of left ventricular systolic dysfunction in a tachycardia-induced porcine model of heart failure. BACKGROUND Furosemide activates the renin-angiotensin-aldosterone system in patients with congestive heart failure (CHF). Such activation may contribute to CHF progression, but prospective data are lacking. METHODS Thirty-two Yorkshire pigs were randomized to furosemide (1 mg/kg intramuscularly daily, mean 16.1 +/- 0.9 mg) or placebo. Thereafter, a pacing model of heart failure was utilized to produce systolic dysfunction in both sets of animals (fractional shortening <0.16 by echocardiogram). The goal was to determine if furosemide would accelerate the progression of left ventricular dysfunction in the "treated" group. After sacrifice, sodium-calcium exchanger currents and their responsiveness to isoproterenol were measured during voltage clamp. All investigators were blinded to treatment assignment. RESULTS Furosemide shortened the time to left ventricular dysfunction (35.1 +/- 5.1 days in placebo versus 21.4 +/- 3.2 days for furosemide animals; p = 0.038, log-rank test). By day 14, aldosterone levels were significantly higher in furosemide animals (43.0 +/- 11.8 ng/dl vs. 17.6 +/- 4.5 ng/dl; p < 0.05). Serum sodium was reduced (133.0 +/- 0.9 mmol/l furosemide vs. 135.7 +/- 0.8 mmol/l placebo; p < 0.05), but no difference in norepinephrine, potassium, magnesium, creatinine, or urea nitrogen was present. Basal sodium-calcium exchanger currents were significantly increased and isoproterenol responsiveness depressed by furosemide. CONCLUSIONS Tachycardic pigs given furosemide had significant acceleration of both contractile and metabolic features of CHF, including left ventricular systolic dysfunction, elevated serum aldosterone levels, and altered calcium handling in a controlled experimental model of heart failure.
منابع مشابه
فراوانی نارسایی بطن چپ در بیماران مبتلا به بیماری انسدادی مزمن ریوی: گزارش کوتاه
Background: Chronic obstructive pulmonary disease (COPD) and heart failure are prevalent comorbidities affecting a vast proportion of the world population, responsible for significant morbidity and mortality, their coexistence is more frequent than previously recognized that poses important diagnostic and therapeutic challenges. We intend to determine the prevalence of concomitant left ventricu...
متن کاملHigh myocardial 18F-FDG uptake after chemotherapy in the presence of left ventricular dysfunction as well as 3-month later with no left ventricular dysfunction
Diffusely increased glucose metabolic activity in the right and left ventricles using 2-deoxy-2-(F-18) fluoro-D-glucose positron emission tomography/computed tomography (18F-FDGPET/CT) and global left ventricular hypokinesia at echocardiography can be evident in acute myocarditis. But, there has been no case report that the ventricular 18F-FDGuptake remains unchanged even ...
متن کاملBackground & Objective : Heart failure is a clinical syndrome and increases in rate by aging. Because changes in ECG and electrolytes are variable, specific and sometimes independent to the disease with different methods to be diagnosed, in this study we tried to find a way to diagnose them. Materials & Methods: This is a retrospective descriptive-analytic study. Data was collected from dec...
متن کاملبررسی فراوانی نشانگر CTnI و عوامل مرتبط با آن در بیماران با دیاستولیک دیس‌فانکشن AHF (PEF)
Abstract Background: Diastolic heart failure comprises 50 percent of cases of heart failure. The implications of increased levels of cardiac troponin I (CTnI) on congestive heart failure with preserved systolic function (AHF PEF) have been poorly evaluated. We hypothesized that its level might be elevated in AHF PEF so this evaluation was done in patients referred to Taleghani hospital with ...
متن کاملPrevalence of Heart Failure in the Cases of Beta-thalassemia Major; Two Years Follow-Up
Inroduction: Heart failure (HF) is an important cause of morbidity and mortality in the cases of Beta-thalassemia major. The purpose of this study was to estimate HF prevalence in these patients and to assess the survivability of those who were treated with intensive chelating therapy. Design and methods: This cross sectional study included 72 beta-thalassemia major cases, the mean age at t...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Journal of the American College of Cardiology
دوره 44 6 شماره
صفحات -
تاریخ انتشار 2004